Thales is highlighting the role that its IoT technology is playing in the supply chain for the COVID-19 vaccine. In that regard, the company called particular attention to the activities of Dyzle, which develops comprehensive monitoring solutions for pharmaceutical companies and other organizations that need to be able to guarantee the integrity of a product in transit.
To that end, Dyzle provides its customers with the hardware needed to monitor factors like temperature, humidity, and pressure, as well as a software portal that makes it easy to track that data in real time. Sensitive products like the COVID-19 vaccine need to be kept in a stable, frozen environment. Dyzle’s solutions allow its customers to comply with the latest GDP regulations for the distribution of medical products, and ensures that those vaccines are still safe to use when they arrive at their intended destination.
In doing so, Dyzle also takes advantage of the latest IoT technologies. In the past, vehicles would be outfitted with closed monitoring systems, each of which would run on a local computer dedicated to the purpose. As a result, companies using those legacy systems would not have any insight into the conditions in their vehicles while they were on the road.
Dyzle’s sensors, on the other hand, are built with Thales Cinterion IoT Modules, which enable cellular connectivity. Those connected devices allow customers to check on the status of a shipment in real time, creating more accountability in the vaccine chain. They are also more flexible and more scalable than traditional solutions, and do not require the installation of any additional IT infrastructure.
At the moment, Dyzle is using two versions of the Thales Cinterion PHS8-P IoT Module, though it is in the process of transitioning to the Cinterion PLS63-W LTE Cat.1 Module. The company purchases its modules through MCS, which acts as a Thales distributor.
“We trust MCS and Thales to deliver high quality IoT Modules to keep our cold chain monitoring and management solutions connected 24/7 from anywhere in the world,” said Dyzle Product Development Manager Sander Hulsbergen. “MCS provides expert support whenever we need it. They offer regular updates and recommendations about mobile network developments along with relevant cellular module roadmaps.”
Dyzle operates primarily in Belgium, Germany, the Netherlands, and Singapore, but plans to expand to other regions in the near future. Thales has emphasized the importance of cybersecurity in the healthcare industry, and acquired the Cinterion portfolio when it acquired Gemalto in early 2019.